Synergistic effects of the sesquiterpene lactone, EPD, with cisplatin and paclitaxel in ovarian cancer cells

BACKGROUND: Ovarian cancer remains still the leading cause of death of gynecological malignancy, in spite of first-line chemotherapy with cisplatin and paclitaxel. Although initial response is favorably, relapses are common and prognosis for women with advanced disease stays poor. Therefore efficaci...

Descripción completa

Detalles Bibliográficos
Autores principales: van Haaften, Caroline, Boot, Arnoud, Corver, Willem E, van Eendenburg, Jaap DH, Trimbos, Baptist JMZ, van Wezel, Tom
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4472250/
https://www.ncbi.nlm.nih.gov/pubmed/25907439
http://dx.doi.org/10.1186/s13046-015-0157-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4472250/
https://www.ncbi.nlm.nih.gov/pubmed/25907439
http://dx.doi.org/10.1186/s13046-015-0157-2

Ejemplares similares